Genmab Completes Acquisition of ProfoundBio - Genmab A/S
May 21, 2024 · Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash. Acquisition gives Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan (Rina-S), plus ProfoundBio’s novel …
News & Insights - Genmab
May 29, 2024 · Discover how Genmab makes a positive impact for patients, communities, employees and the environment. Corporate and financial resources for Genmab investors, potential shareholders and analysts. Find press releases, …
Genmab to Showcase Strength and Breadth of Comprehensive …
Nov 5, 2024 · Genmab A/S. Media Release COPENHAGEN, Denmark; November 5, 2024. More than 20 abstracts, including four oral presentations, with new clinical data across lines of therapy and subgroups of non ...
Home | Genmab
Discover how Genmab makes a positive impact for patients, communities, employees and the environment. Corporate and financial resources for Genmab investors, potential shareholders and analysts. Find press releases, articles and access media from Genmab.
Genmab to Broaden and Strengthen Oncology Portfolio with
Apr 3, 2024 · Company Announcement. Genmab to acquire ProfoundBio for USD 1.8 billion in cash. Acquisition will give Genmab worldwide rights to three candidates in clinical development, including...
Genmab Announces Financial Results for the First Nine Months of …
Sep 30, 2024 · Net financial items resulted in income of DKK 1,019 million for the first nine months of 2024 compared to DKK 1,060 million in the first nine months of 2023. Genmab is updating the lower end of its revenue range of 2024 financial guidance driven by higher total royalty revenues from DARZALEX. Genmab is also lowering the upper end of its ...
Genmab to Showcase Strength and Breadth of ... - Business Wire
Nov 5, 2024 · Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody ...
Genmab to Showcase Strength and Breadth of Comprehensive …
Nov 5, 2024 · Genmab does not undertake any obligation to update or revise forward looking statements in this Media Release nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. ... News & Insights Find updates, articles and access media from Genmab. News ...
Genmab Launches “AI Everywhere”
Sep 19, 2024 · As a company that has recently tripled in size, Genmab wanted to use AI to address operational challenges—and develop new ways of working with vast amounts of complex scientific data. Just one month after ChatGPT Enterprise launched, Genmab rolled …
Genmab to Broaden and Strengthen Oncology Portfolio with ... - Nasdaq
Apr 3, 2024 · COPENHAGEN, Denmark and SEATTLE, Washington; April 3, 2024 – Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. announced today that the companies have entered into a definitive agreement for...